Abstract: This document describes the application of the syntax, semantic rules, and format of the Nomenclature for Properties and Units (NPU) terminology for coded dedicated kinds-of-property in the subject field of clinical molecular genetics. A vocabulary for NPU definitions in this field, based on international terminology and nomenclature, is introduced and examples of actual NPU definitions for different types of investigations are given and explained.
Preface
The present document is Part XXIV of a series on properties and units in the clinical laboratory sciences initiated in 1987.
The series currently comprises: I Syntax and semantic rules [ 
Foreword and scope
The use of informatics in the health care field, and especially within clinical laboratory sciences, has enabled the communication and storage of clinical laboratory information in a structured manner. The demand for actionable data for clinical purposes, e.g. for enhancement of clinical workflows, data integration to improve detection and treatment of disease, as well as for research and statistics, is progressively increasing. Laboratory information may be used far from its source of origin in both time and space, and agreement on a common, stable, and unequivocal set of terms and definitions is necessary in order to prevent the loss or distortion of their meaning. For two decades, the NPU Terminology has supplied code values and definitions based on international standards, nomenclatures, and terminologies.
This document continues the work published in Part XVIII. Properties and units in clinical molecular biology (IUPAC Technical Report). Its primary purpose is to apply the IUPAC-IFCC recommended syntax structures for requests and reports, providing formats and names of properties observed in the domain of clinical molecular genetics to facilitate unequivocal written or electronic communication among health care professionals.
The scope of this document is limited to human molecular genetics; other medical aspects of genetics, such as biochemical or physiological indicators of genetic variants or molecular genetics of clinically relevant microorganisms, are excluded.
This document is concerned with identifying the properties investigated in a standardized way, but it is equally important that the result values reported are filed and communicated in a standardized way. Any report of a variation of a nucleic acid sequence should include the identity of the sequence referred to and be expressed in a structured manner. For this purpose, the Human Genome Variation Society (HGVS) [18] recommendations for the description of sequence variants [19] are strongly recommended.
3 Concepts, terms and definitions 3.1 General concepts for properties in the clinical laboratory sciences system: a demarcated part or phenomenon of the perceivable or conceivable universe, material or immaterial, that may be regarded as a set of entities, together with a set of relations or processes between these entities [20] .
component: part of a system [20] .
EXAMPLE
The CFTR gene is a component of the system (human) DNA property: state-or process-descriptive feature of a system including any pertinent components [20] .
kind-of-property: aspect common to mutually comparable properties [20] .
dedicated kind-of-property: kind-of-property with given sort of system and any pertinent sorts of component [20] . EXAMPLE DNA(specification)-A1BG gene; sequence variation scale type (or value set type): a kind-of-property may be qualified to narrative values, nominal value set, ordinal scale, differential scale, or rational scale [21] . Kinds-of-property qualified by the last two scale types are are also called kind-of-quantity.
narrative values: values consisting of an unlimited set of possible descriptions of the kind-of-property. A narrative description may specify in detail the actual property or properties investigated and may include information on technique and clinical relevance.
nominal value set: value set with a set of possible values for a given kind-of-property that are each a word or symbol without any relation to magnitude NOTE: The values may be listed in any order according to practical considerations and convention.
category: nominal kind-of-property indicating a class among nominal properties according to values of a specified value set [22] . entitic: numerator kind-of-quantity, usually extensive, divided by number of entities [20] . NOTE: may be combined with kinds-of-property to refer to a single entity (particle) of a system consisting of many like entities.
EXAMPLES
Blood-Erythrocytes; volume = 2.3 litre The total volume of all erythrocytes in the patient's blood is 2.3 litre Blood-Erythrocytes; entitic volume = 87 femtolitre The (mean) volume of one erythrocyte in the patient's blood is 87 femtolitre arbitrary: modifier to kinds-of-property used to denote lack of a common reference for the result value set.
NOTE: May be combined with kinds of property to indicate that result values are not comparable unless performed by identical procedures. Arbitrary kinds-of-property are used with all definitions specifying ordinal scale types. They may also be used with ratio scale types, where a SI unit for technical reasons cannot be assigned. In these cases the unit is replaced with the text '(procedure defined unit)' or '(p.d.u)'. Patient-Body; arbitrary mass = high Ordinal scale type The locally defined value set might be e.g. {low, normal, high}
Concepts in dedicated kinds-of-property in the field of clinical molecular genetics
The object of a clinical investigation is a human patient, a part of the patient or a part of the patient's close environment. This document is concerned solely with the terminology for human molecular genetics. Some of the external definitions or references to concepts used in NPU definitions may apply to all kinds of living organisms, but within this document they should be considered only in the context of a human object of investigation.
Terms used in NPU definitions are established with reference to authoritative external definitions, terminologies and nomenclatures where possible (see Terminological references). References are filed in the international NPU data repository. Where no valid reference exists, a local definition or explanation of the term is filed.
Some concepts are central in the field of clinical molecular genetics, and these terms will make up a large part of the semantic content of NPU definitions within this field. A selection of the most important concepts are listed below, with term, abbreviation in parenthesis where relevant, and with a defining reference where possible. Clinical molecular genetics is still an emerging field of science, and in some cases, it has proved difficult to locate a valid external terminological reference. For these concepts a definition or a description of intended meaning is introduced for the purpose of this document only. The list is not final or exclusive; concepts, references and definitions will be continuously added to the NPU data repository as development in the field of molecular genetics continues.
alleles: variant forms of the same gene, occupying the same locus on homologous chromosomes, and governing the variants in production of the same gene product [23] .
clonality: kind-of-property indicating the property of cells related by descent from a single progenitor cell [24] . Value sets are ordinal.
chromosomes (chroms):
In a prokaryotic cell or in the nucleus of a eukaryotic cell, a structure consisting of or containing DNA which carries the genetic information essential to the cell [23] . In this context the chromosomes contained in a human individual, or part of the individual, tissue or cell line [25] , including protein components, e.g. histones.
copy number variation (cnv): kind-of-property designating structural variation in the number of copies of one or more specific sequences from a reference sequence of the same kind. The results are narrative.
NOTE: This includes deletion of sequences (number of copies = 0). 'Loss of Heterozygosity' (LOH) and 'gene amplification' are subtypes of specific copy number variations. Used to describe large copy segments, of thousands to millions of DNA bases, but there is no international agreement as to size limits. The reference sequence must be stated either via the NPU definition or as part of the report. Result values reported with the same NPU code cannot be assumed comparable unless investigated and reported by identical procedures.
disomy type: classification describing the parental origin of genetic material, e.g. maternal, paternal, uniparental or biparental disomy, isodisomy, heterodisomy.
DNA: a deoxyribonucleotide polymer that is the primary genetic material of all cells [23] . In this context DNA contained in a human individual, or part of the individual -tissue, cell line [25] or fluid of a patient. May be specified as to origin (for example leukocytes from blood, tumoral cells from renal tissue, or (cell-free) plasma).
DNA fragment:
A sequence of DNA, shorter than a whole chromosome. NOTE: Free DNA fragments are present in blood plasma. They represent genetic material from the person, including tumors and transplants, and, in pregnant women, genetic material from the fetus. entitic number (entitic num.): entitic kind-of property designating the number of a component in a single entity of the system, e.g. the number of specific repeats of a sequence in the genome. The value set is a ratio scale of natural numbers.
exome: That part of the genome that corresponds to the complete complement of exons of a cell [23] .
gene: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms [23] .
genome: The genetic complement of an organism, including all of its genes, as represented in its DNA, or in some cases, its RNA [23] . In this context an entity of an individual's complete set of DNA, including all of its genes. gene rearrangement: Any DNA sequence rearrangement that results in the creation of a novel proteincoding capacity [24] . immunoglobulin gene rearrangement: gene rearrangement that creates a novel junction among the immunoglobulin-coding variable, diversity, joining or constant segments [24] .
haplotype: a set of genes that are closely linked and tend to be inherited together [23] .
karyotype: An entity of the complete set of chromosomes in an individual, tissue or cell line [25] .
methylation:
The covalent chemical or biochemical addition of a methyl group(s) to a compound [24] .
reference sequence: A sequence of like entities (nucleotides, amino acids) adopted by convention, with which any other sequence of the same kind can be compared to identify deviations from the sequence NOTE: a reference sequence may be stated by reference to an internationally recognized source, e.g. NCBI Reference Sequence Database [26] NOTE: The particular sequences investigated must be stated as part of the report. The reference sequence must be stated either via the NPU definition or as part of the report. Results reported with the same NPU code cannot be assumed comparable unless investigated and reported by identical procedures. The abbreviation 'var.' for this term is avoided, to keep the expression in daily use of this very unspecific kind-of-property distinctly different from abbreviations of the more specific kinds-of-property 'seq.var.' and 'struc.var'.
transcriptome: An entity of the complete set of RNA transcripts from DNA in a cell or tissue. The transcriptome includes ribosomal RNA (rRNA), messenger RNA (mRNA), transfer RNA (tRNA), micro RNA (miRNA), and other non-coding RNA (ncRNA).
uniparental disomy (upd): disomy type indicating the presence in a cell of two paired chromosomes from the same parent, with no chromosome of that pair from the other parent [23] .
Syntax and semantic content 4.1 The NPU concept model
An examination as a scientific process investigates one or more properties of a system. In human clinical sciences, the object of investigation may be a certain patient, a part of the patient, or part of his close environment; and in the field of clinical laboratory sciences the actual patient system investigated is often, but not always, represented by a physical sample.
The result of a clinical laboratory investigation, in e.g. a message or health care record concerning a certain patient, may be identified by stating the system investigated, the component studied in that system and the property estimated of that component in that system, with a measurement unit specified where relevant. The NPU terminology supplies definitions of such types of properties dedicated to specific systems and components, according to specific syntax and semantic rules [1] . Such a definition is also referred to as a 'dedicated kind-of-property'.
The semantic content is established with references to international nomenclatures, terminologies and classifications of the relevant scientific field where possible. The sources for semantic content in the field of human molecular genetics are listed in 'Terminological References'
The general structure of a NPU definition is:
System(system specification)-Component(component specification); kind-of-property (procedure specification) = ? unit of measurement The parts System, Component and kind-of-property are mandatory for all definitions, as is a unit where relevant. Specifications may be added as needed. For everyday use an abbreviated string is employed, where the term of any part except the Component may be replaced by an abbreviation. This representation is used for most examples in this document.
A marker in place of a specification (written 'specification', abbreviated 'spec.', or 'procedure', abbreviated 'proc.'), indicates that the NPU definition does not supply all details needed to define the patient property investigated. The investigating laboratory must supply the clinically relevant missing information.
Each definition is assigned an identifier (NPUxxxxx) intended to represent that definition in health informatics applications. The identifier enables laboratory data to be transmitted, used, and safely stored in e.g. laboratory information management systems, electronic health care records, and research databases, and allows for variation in naming conventions. The connection between NPU identifiers and NPU definitions will always be available, and will not change over time or geography.
In this document established NPU definitions are shown with their actual NPU identifier, as filed in the NPU database. Where examples of definitiones are not (yet) in actual use, the potential identifier is represented by 'NPUxxxxx'. 
Naming investigations and their results
There is no demand that the NPU definition or its abbreviated expression serves as the only name or the common name for investigations or results in local systems, or in digital laboratory reports. The abbreviated NPU expressions have proved generally useful as primary names, but because of the formalized structure and wording, they can in some cases be very different from commonly used terms or be very long and unwieldy.
It is recommended that systems presenting laboratory data make the NPU abbreviated expressions and identifiers, together with local terms, available to users. Whether to use local terms or the NPU expressions as primary names is a matter of local preference.
System and system specification
Common systems in clinical molecular genetics are chromosomes, DNA and RNA. The system may be specified, partly specified or unspecified.
A marker in place of a system specification (written 'specification', abbreviated 'spec.'), indicates that the NPU definition does not necessarily supply all details on the system. Supplementary information on the exact system, e.g. that the investigation concerns a specific tissue of the patient, may need to be communicated by other means. If no such extra information is supplied, it may be assumed that the system is the germline system of the patient in question. 
Component and component specification
As a general rule, for genes and chromosomes the component is the representative (entitic) instance, not the total number or mass of like elements in the system.
Specifications to the component may indicate a specific type, variant or part of the general concept. Specific variants may be described using a Locus Reference Genomic (LRG) reference sequence [27] followed by the variant description (according to the general recommendation of HGVS Variant Description Nomenclature). If a LRG reference is not available, the variant investigated may be described using a RefSeqGene record from the RefSeq database [26] , listing both database accession and version number. For reasons of terminological consistency the genomic (NG_) sequences are preferred.
EXAMPLES -BRCA1 gene;
The component investigated is the BRCA1 gene or unspecified parts of it.
-BRCA1 gene(LRG_292:g.124140)
The component investigated is a specific part of the BRCA1 gene, specified according to a reference sequence.
-BRCA1 gene(LRG_292:g.124140C > T) The component investigated is a specific variant in a specific position of the BRCA1 gene, specified according to a reference sequence.
-JAK2 gene(LRG_612t1:exon 12); The component investigated is a specific part of the JAK2 gene, exon 12, specified according to a transcript reference sequence.
-MT-ATP6 gene(NC_012920.1:m.8993T > G); The component investigated is a specific variant in a specific position of the mitochondrial MT-ATP6 gene. The position is specified according to a reference sequence.
-HLA-B gene( * 27); The component investigated is a specific allele type of the HLA-B gene.
-Genome (16p2-p3) ; The component investigated is a specific part of the DNA of chromosome 16.
-Genome (methylated); The component investigated is methylated DNA.
-Genome (15q11-q13; methylated); The component investigated is methylated DNA in the region 15q11-q13 of chromosome 15.
Kinds-of-property and procedure specification
The most frequent kinds-of-property in the field of human molecular genetics will be 'variation', 'sequence variation' (seq.var.), 'structure variation' (struc.var) and 'copy number variation' (cnv), all used with narrative result values.
Apart from 'sequence variation', which indicates that the full sequence in question has been investigated, all other kinds-of-property are used with the marker 'procedure' (proc.) to indicate that result values identified with the same NPU code may not be assumed comparable unless produced by identical procedures.
The technique employed and the variants investigated should be reported as a structured part of the result if clinically relevant.
To describe the variations recommendations from HGVS should be followed. NOTE: This variant is generally referred to as "FMR1, (CGG)n EXPANSION". This is not according to HGVS nomenclature [18] , which has the so called "3′ rule". This rule states that:
for all descriptions the most 3′ position possible of the reference sequence is arbitrarily assigned to have been changed
Applied to the FMR1 gene and the repeat in the 5′UTR the unit of this repeat is GGC (it ends with ...cggcggcggcggcggc ggc tgggcctc) and not CGG. The narrative result will express the copy number variation in the 17q11.2 region in the NF1 gene.
The modifier 'entitic' is not used with the four kinds-of-property mentioned above, as it is implicitly assumed. For other kinds-of-property in general use in NPU definitions, with result value sets of ratio scale type and ordinal scale type, the modifier 'entitic' is needed if the object of investigation is a single instance of the system.
Ratio scale type. If a number of a variant in a single instance of the genome is stated as result, the kind-ofproperty is 'entitic number' (entitic num.) with a value set of natural numbers stating the number of copies of the gene or the variant. Quantitative results based on counting totals in body fluids or tissues (e.g. DNA fragments in plasma) may be described using 'number concentration' (num.c.) for fluid systems, 'number content' for solid systems, or 'number fraction' (num.fr.), such as in NPU definitions describing cell counts in body fluids or tissues.
Ordinal scale type. When the result is a value on an ordinal scale, the term 'arbitrary' is added to the kind-of-property to indicate the lack of a reference measurement unit. For value sets describing the presence or absence, or some other sort of arbitrary count in a genetic entity, the kind-of-property will be arbitrary entitic number (arb.entitic num.).
For value sets expressing amounts of substances or sequences in the whole system, the kind-of-property will be 'arbitrary content' (arb.cont.) for solid systems and 'arbitrary concentration' (arb.c.) for fluid systems.
EXAMPLES
NPUxxxxx DNA(spec.)-KRAS gene (NG_007524.1:g.10571G > T) arb.entitic num.(proc.) = 1 Only presence or absence of the sequence variation has been tested. The laboratory uses an arbitrary ordinal scale of 0 -not present, 1 -present. This patient has the sequence variation in at least one allele.
NPU53657 RNA(spec.)-SOX11 gene; arb.cont.(proc.) = Increased expression The result expresses the amount of a specific gene sequence in the total RNA system. The value set used by the laboratory is {Decreased expression, Normal, Increased expression}. As RNA is a solid, the kindof-property is 'arbitrary content'.
Nominal scale type.
If the result is a type or classification with a limited and known value set, the kindof-property will be 'category'. The modifier 'entitic' is not needed for nominal value sets. The value set or classification system used should be specified by the laboratory. NOTE: An open-ended value set of {haploid, diploid, triploid, tetraploid, pentaploid …} expresses a number of copies, with the terms representing natural numbers on a ratio scale. The kind-of-property will be 'entitic number'.
EXAMPLES

Measurement unit
Measurement units are rare in this field. Where relevant, SI units or SI accepted units are used [1] . The unit 'one' (symbol '1') of dimensionless quantities is not stated.
Types of Dedicated kinds-of-property in human molecular genetics
5.1 Properties of specified DNA/RNA sequences
Single genes, or unspecified variants or sequences of single genes
The general model suggested in Part XVIII [14] is continued. The reference for gene names is the HUGO Gene Nomenclature Committee (HGNC) [28] and the result scale type is generally narrative, with four kindsof-property of increasing specificity available (variation, sequence variation, structure variation, and copy number variation), depending on the scope of the investigation.
Result values that are narrative should include the specification of the actual sequence(s) investigated and reported on. Use of the HGVS [18] Nomenclature is strongly recommended. 
Specified variants or sequences of single genes
The model from Part XVIII [14] is adjusted; OMIM references to variants are replaced by descriptions of the actual sequences.
The choice of kind-of-property may vary depending on the communication needs and the specificity of the result.
If the result is based on the investigation of variants of a shorter specified sequence or a single nucleotide position, the kind-of-property is either 'variation' or 'sequence variation', depending on whether the sequence or variant has been partly or fully investigated.
If the result describes structural changes of larger size, 'structure variation' or 'copy number variation' may be relevant.
If the result is numeric (the variant is present in 0, 1 or 2 copies, i.e. not present, heterozygote, or homozygote for the variant), the kind-of-property is 'entitic number'.
If a specific sequence is indicated, and the result is given as not present or present (0, 1) i.e. a binary ordinal scale, the kind-of-property is 'arbitrary entitic number' (arb. entitic num.) The sequencing of whole exons, especially of more than one exon at the same time, can be specified using a transcript reference sequence and the actual exon numbers (check if other NPU definitions specifying the same sequences or variants are already established with genomic references). 
EXAMPLES
DNA sequences larger than a single gene
Variants of DNA over a larger part of a chromosome than a single gene may be located via their chromosome location using the International System for Human Cytogenetic Nomenclature (ISCN) [25] . The component here is DNA, i.e. a specific part of the genome, not of the chromosome.
EXAMPLE
NPUxxxxx DNA(spec.)-Genome(17p13.3; deletion);cnv(proc.) = ? The result is a narrative description of deletions identified by e.g. FISH technique in the 17p13.3 area. The report must specify the set of deletions investigated.
DNA fragments in blood plasma
The presence of specific DNA fragments in plasma may be estimated using an ordinal scale, or the actual number concentration of specific fragments may be counted. 
EXAMPLES
Fused genes and other structural changes
Fused genes may be identified with reference to the NCI Thesaurus [24] . If no reference is found there, a fusion may be described using ISCN nomenclature [25] . 
HLA and CYP genes
Allele nomenclatures for HLA [29] and CYP [30] gene systems are currently being aligned with the HGVS system. The specific HLA and CYP nomenclatures may be used to specify alleles until the alignment is completed. 
EXAMPLES
Haplotypes
Haplotypes are sets of loci that are closely linked and tend to be inherited together [23] . A haplotype motif is a commonly observed structural component consisting of such loci. 
One examination producing information on groups of genes
Grouped investigations ordered and reported together
Investigations may concern a whole group of related genes or variants. Results may be single values (classifications, patterns) or sets of values, e.g. one for each individual gene or variant.
If several result values are reported, the NPU list structure may be used. The NPU list header defines the complete property investigated and reports a set of individual results, each with their own NPU identifier.
List content examples may be filed with the NPU list entry as an illustration of the meaning of the investigation, or they may be omitted.
In human molecular genetics, sets of genes related to specific syndromes are often examined and reported on together. The reference for phenotypes (syndromes) should be OMIM [31] where possible. Where OMIM lists several related phenotypes corresponding to different genotypes, a phenotypic series ID may serve as a reference. If no phenotypic series ID is available, the reference should be to the OMIM phenotype numbered '1', provided it holds an overview of the related phenotypes.
WHO classifications ICD-10 or ICD-11 may be considered as references for genetic phenotypes if no OMIM reference is available.
Proprietary terms for commercially available panels or arrays are not sufficient to define a set of genes related to a patient property, as they are not based on international nomenclature or terminology and are not unique. As the investigation may comprise result values with different kinds-of-property, e.g. 'cnv', 'seq.var', and 'variation', the list definition must have the least specific kind-of-property relevant (here 'variation').
NPUxxxxx DNA(spec.)-Hypercholesterolemia, familial-related gene;variation (list; proc.)
The result contains detailed information on an unspecified set of genes related to familial hypercholesterolemia. Results are reported for individual NPU-identified genes or variants.
NPUxxxxx RNA(spec.) -Transcriptome; variation(list; proc.) = ?
The result contains detailed information on the transcriptome. Results are reported for individually NPUidentified genes or variants.
The reported investigation result may technically be based on a group of individual investigations, but reduced to a single classification value, e.g. a gene signature, when reported. If only one result value is reported, a single NPU definition, rather than a list structure, is used.
EXAMPLES
NPUxxxxx DNA(Marrow)-T Cell Receptor genes; clonality(proc.) = ? Ordinal scale. The result is based on examination of the genes TRB, TRG and TRD, but only one result value is given, concerning the presence of clones of these 3 genes NPUxxxxx DNA(spec.)-Brugada syndrome related gene; category(pattern;proc.) = ? The result expresses a constitutional type
Large gene domains
Large domains may be identified by specific domain terms. 
Chromosomes and parts of chromosomes
Where the object of investigation is one or more chromosomes or parts of chromosomes, rather than specific genes, the component may be identified according to the ISCN system [25] , and reporting should follow the ISCN nomenclature. For quantitative results, specification of the examined part of the genome is necessary, or the result value will be ambiguous. If this specification is not part of the NPU definition, the information must be supplied as part of the report. Parental imprinting is a class of DNA modification that may be described using HGVS nomenclature, ISCN nomenclature (with narrative value sets), or a nominal value set of 'disomy types', e.g. {uniparental, biparental}. Abbreviated expressions have proved sufficient for the identification of result types in most communication to and from laboratories (e.g. laboratory orders and reports, local documentation, statistics). In this publication, the abbreviated expression is used in all examples of NPU definitions. It is recommended that the unabbreviated definition, including status, value set or scale type, and terminological references are available from e.g. a national resource, in order to resolve cases of doubt.
EXAMPLES
